Reuters logo
4 个月前
BRIEF-Allergan says it has entered into a clinical trial agreement with Novartis to conduct a phase 2b study
2017年4月18日 / 凌晨5点24分 / 4 个月前

BRIEF-Allergan says it has entered into a clinical trial agreement with Novartis to conduct a phase 2b study

April 18 (Reuters) - Allergan Plc

* Announced it has entered into a clinical trial agreement with Novartis to conduct a phase 2b study, using Allergan's Cenicriviroc

* Financial details of this transaction are not disclosed

* Phase 2b study will assess safety, efficacy and tolerability of this multi-therapy treatment approach for NASH

Source text for Eikon:

Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below